Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1712
mi
from 91732
Oak Brook, IL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1712
mi
from 91732
Oak Brook, IL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1182
mi
from 91732
Wichita, KA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1182
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
959
mi
from 91732
Bellevue, WA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
959
mi
from 91732
Bellevue, WA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1899
mi
from 91732
Dothan, AL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1899
mi
from 91732
Dothan, AL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
11
mi
from 91732
Downey, CA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
11
mi
from 91732
Downey, CA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1911
mi
from 91732
Smyrna, GA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1911
mi
from 91732
Smyrna, GA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2180
mi
from 91732
Buffalo, NY
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2180
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2503
mi
from 91732
Stony Brook, NY
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2503
mi
from 91732
Stony Brook, NY
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2194
mi
from 91732
Chapel Hill, NC
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1344
mi
from 91732
The Woodlands, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1344
mi
from 91732
The Woodlands, TX
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2267
mi
from 91732
Richmond, VA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
970
mi
from 91732
Bothell, WA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
970
mi
from 91732
Bothell, WA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Study Site
mi
from 91732
Bourgas,
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Study Site
mi
from 91732
Bourgas,
Click here to add this to my saved trials
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Status: Enrolling
Updated:  1/11/2016
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Status: Enrolling
Updated: 1/11/2016
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
Status: Enrolling
Updated:  1/11/2016
Brown University
2562
mi
from 91732
Providence, RI
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
Status: Enrolling
Updated: 1/11/2016
Brown University
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Emory University/Childrens Healthcare of Atlanta
1922
mi
from 91732
Atlanta, GA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Emory University/Childrens Healthcare of Atlanta
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
1729
mi
from 91732
Chicago, IL
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Riley Children's Hospital
1793
mi
from 91732
Indianapolis, IN
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Riley Children's Hospital
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Johns Hopkins University
2301
mi
from 91732
Baltimore, MD
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Johns Hopkins University
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Harvard University, Boston Children's Hospital
2578
mi
from 91732
Boston, MA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Harvard University, Boston Children's Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
St. Louis Children's Hospital
1570
mi
from 91732
St. Louis, MO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
St. Louis Children's Hospital
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Columbia-Presbyterian
2435
mi
from 91732
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Columbia-Presbyterian
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
1880
mi
from 91732
Cincinnati, OH
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Pittsburgh of UPMC
2121
mi
from 91732
Pittsburgh, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Pittsburgh of UPMC
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Medical Center of Dallas
1221
mi
from 91732
Dallas, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Medical Center of Dallas
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Univ of Washington
961
mi
from 91732
Seattle, WA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Univ of Washington
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Mount Sinai Hosp
2481
mi
from 91732
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Mount Sinai Hosp
2481
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Hospital for Sick Children
2158
mi
from 91732
Toronto,
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Hospital for Sick Children
2158
mi
from 91732
Toronto,
Click here to add this to my saved trials
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated:  1/11/2016
VA San Diego Healthcare System, San Diego, CA
105
mi
from 91732
San Diego, CA
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated: 1/11/2016
VA San Diego Healthcare System, San Diego, CA
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated:  1/11/2016
VA Medical Center, Minneapolis
1509
mi
from 91732
Minneapolis, MN
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated: 1/11/2016
VA Medical Center, Minneapolis
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated:  1/11/2016
VA Medical Center, Portland
827
mi
from 91732
Portland, OR
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated: 1/11/2016
VA Medical Center, Portland
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated:  1/11/2016
VA Long Beach Healthcare System, Long Beach, CA
21
mi
from 91732
Long Beach, CA
Baclofen to Reduce Alcohol Use in Veterans With HCV
Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV
Status: Enrolling
Updated: 1/11/2016
VA Long Beach Healthcare System, Long Beach, CA
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
Strength At Home: Veterans' Program (PTSD-Focused Therapy for Anger and Relationship Conflict Among OEF/OIF Veterans)
Strength At Home: Veterans' Program (Formerly: Post-Traumatic Stress Disorder (PTSD)-Focused Therapy for Anger and Relationship Conflict Among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans)
Status: Enrolling
Updated:  1/11/2016
National Center for PTSD/VA Boston Healthcare System
2578
mi
from 91732
Boston, MA
Strength At Home: Veterans' Program (PTSD-Focused Therapy for Anger and Relationship Conflict Among OEF/OIF Veterans)
Strength At Home: Veterans' Program (Formerly: Post-Traumatic Stress Disorder (PTSD)-Focused Therapy for Anger and Relationship Conflict Among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans)
Status: Enrolling
Updated: 1/11/2016
National Center for PTSD/VA Boston Healthcare System
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Strength At Home: Veterans' Program (PTSD-Focused Therapy for Anger and Relationship Conflict Among OEF/OIF Veterans)
Strength At Home: Veterans' Program (Formerly: Post-Traumatic Stress Disorder (PTSD)-Focused Therapy for Anger and Relationship Conflict Among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans)
Status: Enrolling
Updated:  1/11/2016
Providence VA Medical Center
2562
mi
from 91732
Providence, RI
Strength At Home: Veterans' Program (PTSD-Focused Therapy for Anger and Relationship Conflict Among OEF/OIF Veterans)
Strength At Home: Veterans' Program (Formerly: Post-Traumatic Stress Disorder (PTSD)-Focused Therapy for Anger and Relationship Conflict Among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans)
Status: Enrolling
Updated: 1/11/2016
Providence VA Medical Center
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Social Cognitive Training for Psychosis: Treatment Development
Social Cognitive Training for Psychosis: Phase I Treatment Development
Status: Enrolling
Updated:  1/11/2016
VA Connecticut Healthcare System
2485
mi
from 91732
West Haven, CT
Social Cognitive Training for Psychosis: Treatment Development
Social Cognitive Training for Psychosis: Phase I Treatment Development
Status: Enrolling
Updated: 1/11/2016
VA Connecticut Healthcare System
2485
mi
from 91732
West Haven, CT
Click here to add this to my saved trials